PTC THERAPEUTICS, INC.
PTCT
19 insider filings · Latest: May 8, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 14, 2026 | May 14 7:09 PM | Klein Matthew B. | Proposed Sale | 2,572 | $72.46 | $186.4K | — | View → |
| May 14, 2026 | May 14 4:43 PM | Klein Matthew B. | Proposed Sale | 10,000 | $73.08 | $730.8K | — | View → |
| May 8, 2026 | May 12 9:20 PM | Mark Elliott BouldingEXEC. VP AND CLO | Sale | 3,540 | $78.97 | $279.6K | 105,212(D) | View → |
| May 8, 2026 | May 8 8:15 PM | Boulding Mark Elliott | Proposed Sale | 3,540 | $78.97 | $279.6K | — | View → |
| Apr 21, 2026 | Apr 23 9:20 PM | Matthew B. KleinDirector, CHIEF EXECUTIVE OFFICER | Sale | 2,850 | $70.91 | $202.1K | 394,070(D) | View → |
| Apr 21, 2026 | Apr 21 8:12 PM | Klein Matthew B. | Proposed Sale | 2,850 | $70.94 | $202.2K | — | View → |
| Apr 6, 2026 | Apr 8 9:20 PM | Mark Elliott BouldingEXEC. VP AND CLO | Sale | 2,265 | $69.45 | $157.3K | 105,212(D) | View → |
| Apr 2, 2026 | Apr 6 9:20 PM | Lee Scott GoldenEVP & CHIEF MEDICAL OFFICER | Sale | 829 | $67.99 | $56.4K | 79,115(D) | View → |
| Apr 6, 2026 | Apr 6 8:13 PM | Boulding Mark Elliott | Proposed Sale | 2,265 | $69.44 | $157.3K | — | View → |
| Apr 1, 2026 | Apr 3 9:20 PM | Neil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER | Sale | 52,003 | $69.04 | $3.6M | 60,137(D) | View → |
| Apr 2, 2026 | Apr 2 7:32 PM | Golden Lee Scott | Proposed Sale | 829 | $67.99 | $56.4K | — | View → |
| Apr 1, 2026 | Apr 1 8:46 PM | Almstead Neil Gregory | Proposed Sale | 52,003 | $69.04 | $3.6M | — | View → |
| Mar 12, 2026 | Mar 13 9:20 PM | Matthew B. KleinDirector, CHIEF EXECUTIVE OFFICER | Sale | 2,662 | $64.08 | $170.6K | 396,920(D) | View → |
| Mar 10, 2026 | Mar 12 9:20 PM | Stephanie OkeyDirector | Sale | 15,167 | $70.00 | $1.1M | 8,000(D) | View → |
| Mar 12, 2026 | Mar 12 7:23 PM | Klein Matthew B. | Proposed Sale | 2,662 | $64.08 | $170.6K | — | View → |
| Mar 10, 2026 | Mar 10 6:12 PM | Okey Stephanie | Proposed Sale | 15,167 | $70.00 | $1.1M | — | View → |
| Mar 5, 2026 | Mar 9 9:20 PM | Stephanie OkeyDirector | Sale | 6,333 | $63.38 | $401.4K | 8,000(D) | View → |
| Mar 5, 2026 | Mar 9 9:20 PM | Lee Scott GoldenEVP & CHIEF MEDICAL OFFICER | Sale | 10,000 | $63.38 | $633.8K | 79,944(D) | View → |
| Mar 5, 2026 | Mar 9 9:20 PM | Neil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER | Sale | 3,989 | $63.38 | $252.8K | 2,737(I) | View → |
| Mar 5, 2026 | Mar 5 6:41 PM | Okey Stephanie | Proposed Sale | 6,333 | $63.38 | $401.4K | — | View → |
Page 1 of 8
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 8, 2026 | May 12 9:20 PM | Mark Elliott BouldingEXEC. VP AND CLO | Option Exercise | 3,540 | $46.54 | 41,460(D) | View → |
| Apr 6, 2026 | Apr 8 9:20 PM | Mark Elliott BouldingEXEC. VP AND CLO | Option Exercise | 2,265 | $39.42 | 6,798(D) | View → |
| Mar 24, 2026 | Mar 26 11:41 PM | Jessica Caroline ChutterDirector | Grant/Award | 6,371 | $64.54 | 2,896(D) | View → |
| Mar 10, 2026 | Mar 12 9:20 PM | Stephanie OkeyDirector | Option Exercise | 15,167 | $33.63 | 0(D) | View → |
| Feb 17, 2026 | Feb 19 10:25 PM | Mark Elliott BouldingEXEC. VP AND CLO | Option Exercise | 2,813 | $25.69 | 22,501(D) | View → |